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Abstract 
Study Objective. To evaluate the efficacy of intraperitoneal subdiaphragmatic instillation of 0.5% lidocaine and 
0.5% bupivacaine infiltration of cannula sites to control pain after diagnostic microlaparoscopy. 
Design. Prospective, randomized study. (Canadian Task Force classification I). 
Setting. Day surgery unit of Endogyn Service, Private Endoscopic Associates, Naples, and Department of Gyne- 
cologic and Pediatric Sciences, Reggio Calabria University, Catanzaro, Italy. 
Patients. Forty women treated for infertility. 
Interventions. The treated group received 0.5% intraperitoneal subdiaphragmatic lidocaine 40 ml and 0.5% bupi- 
vacaine 5 ml infiltration of cannula insertion sites. The control group received no treatment. In all patients the 
procedure was performed with atropine 0.5 mg, fentanyl 0. 1 mg, droperidol 5 rag, and local anesthesia. Postop- 
eratively, depending on the need, ketoprofene 100 mg or ketorolac 30 mg was administered intramuscularly. 
Measurements and Main Results. Postoperative pain score was evaluated by visual analog scale immediately post- 
operatively and 1, 3, 6, 12, 24, 36, and 48 hours afterward. The treated group had significantly lower pain scores 
at the end of surgery and at 1-, 3-, (p <0.01), and 6-hour intervals (p <0.05). No significant differences in scores 
between groups were observed starting from 6 hours postoperatively. 
Conclusion. Postoperative intraperitoneal lidocaine and bupivacaine infiltration of cannula sites offered a detectable 
benefit to women undergoing diagnostic microlaparoscopy. The effect was temporary, but induced a significant 
decrease in the postoperative pain for approximately 6 hours. 
(J Am Assoc Gynecoi l aparosc 5(2):161-163, 1998) 
Administration of local anesthesia during lapa- 
roscopy for postoperative pain control has generated 
great interest, as it should allow the procedures tobe 
performed as day surgery under local or regional rather 
than general anesthesia, nd may eliminate the need 
for narcotic analgesics. 1 Indeed, postoperative analgesia 
requirement in day surgery is considered the most 
important factor involved in the delay to returning to 
normal daily activities. 2 Several authors found that 
intraperitoneal administration f a local anesthetic s 
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CTF I: Evidence obtained from a properly designed, randomized, controlled trial. 
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effective in reducing the intensity of postoperative 
pain after diagnostic laparoscopy, 3 laparoscopic ster- 
ilization, 4-7 operative laparoscopyp and laparoscopic 
cholecystectomy. 1 
Materials and Methods 
The 45 women in this preliminary study had infer- 
tility lasting more than 2 years and agreed to undergo 
diagnostic microlaparoscopy under local anesthesia plus 
conscious edation. Before surgery they underwent 
complete clinical history and physical examination, 
with special attention to metabolic or cardiorespira- 
tory contraindications to the procedure. Each patient 
signed informed consent after extensive xplanation 
of the procedure. 
The women were randomly allocated to one of two 
groups according to computer-generated assignment. 
Group A (20 women, mean + SD age 32.3 + 4.2 yrs, 
weight 65.6 + 6.3 kg) received intraperitoneal subdi- 
aphragmatic instillation of 0.5% lidocaine 40 ml and 
infiltration of cannula insertion sites with 0.5 % bupi- 
vacaine 5 ml after microlaparoscopy Group B (20 
women, mean + SD age 33.4 + 5.1 yrs, weight 67.1 + 
5.5 kg) received no postoperative treatment. The five 
patients in in whom microlaparoscopy was converted 
to operative laparoscopy were excluded from data 
analysis. 
Operative Procedure 
The endoscope was the 3.3-mm Microlap (Karl 
Storz, Tuttlingen, Germany) with a zero-degree view. 
A 175-W xenon light source was used for illumina- 
tion and a new-generation videocamera (Telecam; 
Storz) was connected to a super-VHS videorecorder 
and to a high-definition monitor. All operations were 
performed inthe outpatient clinic or a day surgery unit. 
An emergency cart with defibrillator and complete 
anesthesiology set with continuous electrocardio- 
graphic monitoring was available during the procedure. 
Atropine 0.5 mg and fentanyl 0.1 mg were admin- 
istered preoperatively, followed by slow intravenous 
injection of droperidol (maximum dose 5 mg). After 
the abdomen was cleansed, 1% mepivacaine 10 ml was 
injected slowly periumbilically descending gradually 
deeper through peritoneum. After making a subum- 
bilical skin incision, a 4.1-mm minitrocar-cannula 
was pushed irectly through peritoneum. The 3.3-mm 
microendoscope was inserted with insufflation of 
about 2 L carbon dioxide. The ancillary site, in the mid- 
line near the hairline, was anesthetized in the same 
manner as the primary site, and a micrograsper was 
inserted through a 14-gauge needle to obtain reliable 
pain mapping in case of chronic pelvic pain, and to view 
the fimbrial end of the fallopian tube at the time of 
chromoperturbation. 
Mean + SD operating times were 26.2 + 4.1 and 
27.7 + 4.4 minutes in groups A and B, respectively (NS). 
The women were observed in the recovery room 
for at least 2 hours and discharged once they were free 
of discomfort. 
Evaluation of Pain 
A global impression of pain control during the pro- 
cedure was obtained by asking each patient for her eval- 
uation on a scale of 1 to 4 (excellent, good, sufficient, 
poor). The postoperative pain score was determined 
immediately after surgery and at 1-, 3-, 6-, 12-, 24-, 
36-, and 48-hour intervals on a visual analog scale 
(VAS) of 1 to 10 (none-intolerable). 9 Patients were 
given a questionnaire garding pain that was repre- 
sentative of the VAS. They were also asked to record 
analgesics taken at home. 
Data Analysis 
The goal of the study was to enroll at least 30 
patients per group, which would give more than 80% 
power to detect adifference of 0.75 SD in pain score 
at the ~ level of 0.05. Preliminary results in 40 women 
yielded a probability of 0.808. 
Statistical analysis was performed with com- 
mercial software (STATISTICA for Windows, Statsoft, 
Inc.). Differences in age and weight were compared 
by two-tailed t test for unpaired ata. The need for post- 
operative analgesics was evaluated by ~2 test. Repeated 
measures analysis of variance was performed todetect 
differences in postoperative pain scores between 
groups. Differences in operating time were compared 
by Wilcoxon rank sum test. In all analyses, statistical 
significance was assessed at 5%. 
Results 
Pain scores during the procedure were not statis- 
tically different between groups (2.5 + 0.7 and 2.7 + 
0.8, respectively, p >0.05). Women in group A had sig- 
nificantly lower scores at the end of surgery and at the 
1-, 3- (p <0.01), and 6-hour (p <0.05) intervals (Fig- 
ure 1). No significant difference was observed between 
groups at 6 hours and beyond. The need for ketorolac 
or ketoprofene analgesia was significantly lower in 
group A (30% vs 75%, p <0.05). 
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FIGURE 1. Postoperative pain score. 
Discussion 
Microlaparoscopy with small-diameter scopes 
enables laparoscopy to be performed in the office and 
outpatient settings. 1~ Our previous tudy showed the 
feasibility of microlaparoscopy without general anes- 
thesia in terms of diagnostic efficacy and pain control 
during the procedure.U Postoperative analgesia remains 
an important challenge, however, 2 and many strategies 
are employed to manage it. 
Intraperitoneal local anesthesia reduced pain after 
laparoscopies that did not require a great deal of dis- 
section or manipulation of viscera. 3After diagnostic 
laparoscopy, 63 % of patients treated with lidocaine or 
bupivacaine were pain free, compared with 33% of 
those who received no treatment. 3 Postoperative lido- 
caine resulted in less shoulder and pelvic pain, as well 
as a lower rate of analgesic requirements after lapa- 
roscopic tubal sterilization. 4 Intraoperative etidocaine 
reduced pain after tubal ligationr Patients had a sig- 
nificant reduction of analgesic requflement when bupi- 
vacaine was injected irectly into the fallopian tubes 
during intravenous edation, compared with women 
receiving only general anesthesia for tubal steriliza- 
tion. 6 Postoperative pain relief also was achieved by 
administering local anesthetics after operative lapa- 
roscopy 8and laparoscopic cholecystectomy. ~ 
Preliminary results of our study indicate ffective 
pain control with postoperative infiltration of cannula 
sites with bupivacaine and subdiaphragmatic instilla- 
tion of lidocaine, and underscore the feasibility of 
microlaparoscopy. Pain control asted up to 6 hours and 
reduced the requirement for additional analgesia. In 
addition, this simple approach was cost effective, and 
enhanced patient safety and ease of recovery. It appears 
to be particularly effective for outpatient minilaparos- 
copies in which the average discharge time is 2 to 3 
hours. 
Given encouraging results from this preliminary 
trial, and eventual confirmation of the results once the 
study is completed, we anticipate incorporating the tech- 
nique as part of our routine pain relief protocol for diag- 
nostic microlaparoscopy as well as for traditional 
laparoscopic procedures. 
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